よむ、つかう、まなぶ。
資料１－２ 調査結果報告書［943KB］ (11 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_45738.html |
| 出典情報 | 薬事審議会 医薬品等安全対策部会安全対策調査会（令和6年度第9回 12／4）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
Not to use potassium supplements or salt substitutes containing
4.5 Interaction with other medicinal products and other forms of
potassium without consulting the prescribing physician [see
interaction
Warnings and Precautions (5.1)].
Pharmacodynamic interactions
Potassium-sparing diuretics and potassium supplements
Due to increased risk of hyperkalaemia, eplerenone should not be
administered to patients receiving other potassium-sparing diuretics and
potassium supplements (see section 4.3).
Potassium-sparing diuretics may also potentiate the effect of antihypertensive agents and other diuretics.
ヨウ化カリウム
米国添付文書（USPI）
欧州添付文書
（2023 年 8 月版）
（2024 年 5 月 29 日版）
4.4 Special warnings and precautions for use
Potassium salts should be given cautiously to patients with renal or
adrenal insufficiency, acute dehydration or heatcramp.
Care should be exercised if potassium salts are given concomitantly
関連記載なし
with potassium-sparing diuretics, as hyperkalaemiamay result (see
section 4.5).
4.5 Interaction with other medicinal products and other forms of
interaction
Several drugs, such as captopril and enalapril can cause hyperkalaemia
10
Not to use potassium supplements or salt substitutes containing
4.5 Interaction with other medicinal products and other forms of
potassium without consulting the prescribing physician [see
interaction
Warnings and Precautions (5.1)].
Pharmacodynamic interactions
Potassium-sparing diuretics and potassium supplements
Due to increased risk of hyperkalaemia, eplerenone should not be
administered to patients receiving other potassium-sparing diuretics and
potassium supplements (see section 4.3).
Potassium-sparing diuretics may also potentiate the effect of antihypertensive agents and other diuretics.
ヨウ化カリウム
米国添付文書（USPI）
欧州添付文書
（2023 年 8 月版）
（2024 年 5 月 29 日版）
4.4 Special warnings and precautions for use
Potassium salts should be given cautiously to patients with renal or
adrenal insufficiency, acute dehydration or heatcramp.
Care should be exercised if potassium salts are given concomitantly
関連記載なし
with potassium-sparing diuretics, as hyperkalaemiamay result (see
section 4.5).
4.5 Interaction with other medicinal products and other forms of
interaction
Several drugs, such as captopril and enalapril can cause hyperkalaemia
10